Evidence map›Paper›PMID 28560160›Full record

ArticleNeuroImage. Clinical2017

Application of calibrated fMRI in Alzheimer's disease.

Isabelle Lajoie, Scott Nugent, Clément Debacker, Kenneth Dyson, Felipe B Tancredi, AmanPreet Badhwar, Sylvie Belleville, Yan Deschaintre, Pierre Bellec, Julien Doyon and 7 more

Open access · goldAbstract read
In one paragraph

Article in NeuroImage. Clinical, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Biomarkers of aging.Science China. Life sciences · 2023
    Review
  15. Article
  16. Review
  17. Mapping oxidative metabolism in the human brain with calibrated fMRI in health and disease.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Article
  18. A flow-diffusion model of oxygen transport for quantitative mapping of cerebral metabolic rate of oxygen (CMROJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 2 countries.

Isabelle LajoieDépartement de Pharmacologie et physiologie, Université de Montréal, Montreal, QC, Canada; Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montreal, QC, Canada; Montreal Neurological Institute, Montreal, QC, Canada. Electronic address: isabelle.lajoie@mail.mcgill.ca.
Scott NugentCentre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montreal, QC, Canada; Montreal Neurological Institute, Montreal, QC, Canada; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
Clément DebackerCentre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montreal, QC, Canada; Montreal Neurological Institute, Montreal, QC, Canada; Department of Psychiatry, McGill University, Montreal, QC, Canada.
Kenneth DysonCentre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montreal, QC, Canada; Montreal Neurological Institute, Montreal, QC, Canada; Department of Physiology, McGill University, Montreal, QC, Canada.
Felipe B TancrediDepartamento de Radiologia, Centro de Pesquisa em Imagem, Hospital Israelita Albert Einstein, São Palo, SP, Brazil.
AmanPreet BadhwarCentre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montreal, QC, Canada; Department of Computer Science and Operations Research, Université de Montréal, Montreal, QC, Canada.
Sylvie BellevilleCentre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montreal, QC, Canada; Département de Psychologie, Université de Montréal, Montreal, QC, Canada.
Yan DeschaintreDépartement de Neurosciences, Université de Montréal, Montreal, QC, Canada; Service de neurologie, Département de Médecine, CHUM Notre-Dame, Montréal, QC, Canada.
Pierre BellecCentre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montreal, QC, Canada; Department of Computer Science and Operations Research, Université de Montréal, Montreal, QC, Canada.
Julien DoyonCentre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montreal, QC, Canada; Département de Psychologie, Université de Montréal, Montreal, QC, Canada.
Christian BoctiDivision de Neurologie, Faculté de Médecine et des Sciences de la Santé & Research Centre on Aging, Université de Sherbrooke, Sherbrooke, QC, Canada.
Serge GauthierMcGill Center for Studies in Aging, Douglas Mental Health Research Institute, Montreal, QC, Canada.
Douglas ArnoldMontreal Neurological Institute, Montreal, QC, Canada; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
Marie-Jeanne KergoatCentre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montreal, QC, Canada; Département de Médecine, Université de Montréal, Montreal, QC, Canada.
Howard ChertkowCentre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montreal, QC, Canada; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada; Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, QC, Canada.
Oury MonchiCentre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montreal, QC, Canada; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada; McGill Center for Studies in Aging, Douglas Mental Health Research Institute, Montreal, QC, Canada; Department of Clinical Neurosciences and Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Richard D HogeDépartement de Pharmacologie et physiologie, Université de Montréal, Montreal, QC, Canada; Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montreal, QC, Canada; Montreal Neurological Institute, Montreal, QC, Canada; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
Montreal Neurological Institute and Hospital · CAInstitut Universitaire de Gériatrie de Montréal · CADouglas Mental Health University Institute · CAHôpital Notre-Dame · CAHospital Israelita Albert Einstein · BRJewish General Hospital · CAUniversité de Sherbrooke · CAUniversity of Calgary · CA

Funding

CIHR MOP 123492
6 · The paper itself

Abstract

Calibrated fMRI based on arterial spin-labeling (ASL) and blood oxygen-dependent contrast (BOLD), combined with periods of hypercapnia and hyperoxia, can provide information on cerebrovascular reactivity (CVR), resting blood flow (CBF), oxygen extraction fraction (OEF), and resting oxidative metabolism (CMRO

Indexed as

AgedAged, 80 and overAlzheimer DiseaseCalibrationCerebrovascular CirculationFemaleFunctional NeuroimagingHumansMagnetic Resonance ImagingMaleOxygenSpin LabelsOxygenSpin LabelsAlzheimer's diseaseBOLD calibration constantCalibrated fMRICerebral blood flowCerebrovascular reactivityOxidative metabolismOxygen extraction fraction

Identifiers

PMID28560160
PMCPMC5443910
OpenAlexW2615209167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.